Sirolimus for treatment of refractory primary warm autoimmune hemolytic anemia in children.

Sirolimus for treatment of refractory primary warm autoimmune hemolytic anemia in children. Blood Cells Mol Dis. 2020 Mar 16;83:102427 Authors: Williams O, Bhat R, Badawy SM PMID: 32220699 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32220699?dopt=Abstract

Source: Blood Cells, Molecules and Diseases - March 15, 2020 Category: Hematology Authors: Williams O, Bhat R, Badawy SM Tags: Blood Cells Mol Dis Source Type: research

More News: Anemia | Autoimmune Disease | Children | Hematology | Science